[go: up one dir, main page]

MX9706424A - Uso de la moxonidina para el tratamiento de la aterosclerosis. - Google Patents

Uso de la moxonidina para el tratamiento de la aterosclerosis.

Info

Publication number
MX9706424A
MX9706424A MX9706424A MX9706424A MX9706424A MX 9706424 A MX9706424 A MX 9706424A MX 9706424 A MX9706424 A MX 9706424A MX 9706424 A MX9706424 A MX 9706424A MX 9706424 A MX9706424 A MX 9706424A
Authority
MX
Mexico
Prior art keywords
moxonidine
atherosclerosis
treatment
Prior art date
Application number
MX9706424A
Other languages
English (en)
Other versions
MXPA97006424A (es
Inventor
Hans Jurgen Mest
Original Assignee
Beiersdorf Lilly Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Lilly Gmbh filed Critical Beiersdorf Lilly Gmbh
Publication of MX9706424A publication Critical patent/MX9706424A/es
Publication of MXPA97006424A publication Critical patent/MXPA97006424A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describe el uso de la moxonidina para el tratamiento de la aterosclerosis.
MXPA/A/1997/006424A 1995-02-28 1997-08-22 Uso de la moxonidina para el tratamiento de la aterosclerosis MXPA97006424A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95301295.2 1995-02-28
EP95301295 1995-02-28
PCT/EP1996/000783 WO1996026728A2 (en) 1995-02-28 1996-02-21 Use of moxonidine for the treatment of atherosclerosis

Publications (2)

Publication Number Publication Date
MX9706424A true MX9706424A (es) 1997-11-29
MXPA97006424A MXPA97006424A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
WO1996026728A2 (en) 1996-09-06
EP0812197A2 (en) 1997-12-17
KR19980702511A (ko) 1998-07-15
WO1996026728A3 (en) 1996-10-17
AU4941796A (en) 1996-09-18
CA2212294A1 (en) 1996-09-06
JPH11501020A (ja) 1999-01-26
US5977121A (en) 1999-11-02

Similar Documents

Publication Publication Date Title
ZA964759B (en) Antithrombotic petidoyl heterocycles.
AU6613896A (en) Chemical compounds
AU7443496A (en) Treatment of migraine
AU5750796A (en) System for the treatment of insomnia
AP9600804A0 (en) Therapeutic amides.
AU6513096A (en) Treatment of fabrics
MX9707570A (es) Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria.
AU3717395A (en) Compositions for the treatment of skin disorders
AUPM761094A0 (en) Treatment of hides
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
ZA9610433B (en) Medical use of proteases.
WO1996026728A3 (en) Use of moxonidine for the treatment of atherosclerosis
NO973366L (no) Fremgangsmåte for behandling av multippel sklerose
HU9502623D0 (en) Use of substituted alkyl-nitrates for the treatment of pathologically increased intraocular pressure
AU6829696A (en) Treatment of solutions
AU4546096A (en) Treatment of waste
AUPN221195A0 (en) Combined waste treatment
AU8879691A (en) Treatment of dispersions
MX9603087A (es) Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas.
HK1006776A (en) Use of moxonidine for the treatment of atherosclerosis
AU3247995A (en) Treatment of hides
AU7323091A (en) Treatment of wastewater
AUPN309095A0 (en) Treatment of hides
AUPN495995A0 (en) Treatment of hides